Immunological Considerations for the Development of an Effective Herpes Vaccine
Microorganisms · 06.09.2024 · 12 (9) · 1846
DOI: 10.3390/microorganisms12091846 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 06.09.2024. Verfasst von Mahmoud Singer und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of California Irvine, Irvine, CA 92617, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Research is underway to develop a vaccine to prevent and cure infection from herpes simplex virus (HSV). It emphasizes the critical need for immunization to address public health issues and the shortcomings of existing treatment options. Furthermore, studies on the HSV vaccine advance the field of immunology and vaccine creation, which may help in the battle against other viral illnesses. The current lack of such a vaccine is, in part, due to herpes viral latency in sensory ganglions. Current vaccines rely on tissue-resident memory CD8+ T cells, which are known to provide protection against subsequent HSV reinfection and reactivation without correlating with other immune subsets. For that reason, there is no effective vaccine that can provide protection against latent or recurrent herpes infection. This review focuses on conventional methods for evaluating the efficacy of a herpes vaccine using differential CD8+ T cells and important unaccounted immune aspects for designing an effective vaccine against herpes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of California Irvine, Irvine, CA 92617, USA.
- Department of Translational Research & Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010, USA.
ORCID-Profile: Mahmoud Singer, Mohamed I Husseiny
Zitieren
APA
Singer, M., & Husseiny, M. I. (2024). Immunological Considerations for the Development of an Effective Herpes Vaccine. Microorganisms, 12(9), 1846. https://doi.org/10.3390/microorganisms12091846
Vancouver
Singer M, Husseiny MI. Immunological Considerations for the Development of an Effective Herpes Vaccine. Microorganisms. 2024;12(9):1846. doi:10.3390/microorganisms12091846
BibTeX
@article{Singer2024,
author = {Singer, Mahmoud and Husseiny, Mohamed I},
title = {Immunological Considerations for the Development of an Effective Herpes Vaccine},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {9},
pages = {1846},
doi = {10.3390/microorganisms12091846}
}
EUVIMED